ARTICLE | Company News
Abcodia, Cellmid deal
August 5, 2013 7:00 AM UTC
The companies partnered to validate midkine ( MDK; MK) as a biomarker for cancer diagnosis using Cellmid's MK-ELISA test. The deal covers testing of multiple cancer indications, but the partners will...